ProText Mobility, Inc. (TXTM)

Market Cap	41.32M
Revenue	n/a
Net Income	n/a
Shares Out	8.79B
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,493,993
Average Volume	20,426,926
Open	0.0047
Previous Close	0.0047
Day's Range	0.0044 - 0.0049
52-Week Range	0.0001 - 0.0056
Beta	-2.02
RSI	55.48
Earnings Date	n/a

About Hess Corporation

ProText Mobility, Inc., a biotech company, engages in the development of pharmaceutical botanical medicines. Its medicines are formulated with highly-bioavailable plant extracts. The company is based in Fort Lauderdale, Florida. ProText Mobility, Inc. operates as a subsidiary of Plandaí Biotechnology, Inc.

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Roger Baylis-Duffield
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: TXTM